NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Exobiosphere

Exobiosphere

Private
Esch-sur-AlzetteHealthcare & Life Scienceshttps://www.exobiosphere.com/

Last Round

VC Round

Apr 1, 2026

Total Funding Raised

$3.61M

Company Overview

Exobiosphere is a biotechnology company that develops automated, space-based high-throughput screening platforms to accelerate drug discovery and preclinical research in microgravity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Space Technology, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

space-based drug discoverycontract research organizationCROmicrogravity researchorbital laboratoryspace biotechhigh-throughput screeningHTSbiomedical screeningdisease modelingspace payloadpreclinical researchdrug target identificationspace-ready hardwarenew space

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exobiosphere Comps

Public and private peers based on sector, stage, and business model.

Exobiosphere comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Exobiosphere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2026
SeedNov 3, 2025
SeedApr 4, 2025

Key People

Founding team and executive leadership

Kyle Acierno

CEO & Co-Founder

Founding Team

Exobiosphere Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 15, 2026

    Grew 46% QoQ, from 13 to 19 employees.

  • May 9, 2025

    Grew 100% QoQ from 4 to 8 employees.

Exobiosphere Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exobiosphere Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exobiosphere's valuation, stock price, and market status.

Firmographic Details

HeadquartersEsch-sur-Alzette
Employee Range26
Year Founded2024
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.